An innovative "hybrid" surveillance strategy - highlighted by close cooperation between public health officials and clinical partners - helped Virginia mount an efficient and effective response to the ongoing outbreak of fungal meningitis and other infections, according to a report in the...
IRX Therapeutics, a developer of novel immunomodulators to treat cancer and viral diseases, announced that it has raised $8 million through a note offering to existing shareholders. The new funding will be used to further develop its pipeline of cancer vaccine candidates, including its lead...